Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$649M |
| 2 |
Nike
NKE
|
+$453M |
| 3 |
Tesla
TSLA
|
+$431M |
| 4 |
AstraZeneca
AZN
|
+$389M |
| 5 |
Coca-Cola
KO
|
+$336M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$897M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$578M |
| 3 |
Moderna
MRNA
|
+$438M |
| 4 |
Apple
AAPL
|
+$417M |
| 5 |
Aon
AON
|
+$386M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.55% |
| 2 | Technology | 20.49% |
| 3 | Consumer Staples | 11.15% |
| 4 | Consumer Discretionary | 9.9% |
| 5 | Industrials | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AWH
2126
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
| $1.91M | ﹤0.01% |
39,253
+32,207
| +457% | +$1.99M |
|
2127
ANI Pharmaceuticals
ANIP
$1.76B
| $1.91M | ﹤0.01% |
58,300
-9,079
| -13% | -$282K |
|
|
STXB
2128
DELISTED
Spirit of Texas Bancshares, Inc. Common Stock
STXB
| $1.91M | ﹤0.01% |
78,900
-300
| -0.4% | -$6.9K |
|
2129
AYTU BioPharma
AYTU
$25.5M
| $1.9M | ﹤0.01% |
33,030
+9,162
| +38% | +$688K |
|
2130
CSP Inc
CSPI
$81.1M
| $1.9M | ﹤0.01% |
426,286
-22,290
| -5% | -$108K |
|
2131
Xencor
XNCR
$1.74B
| $1.9M | ﹤0.01% |
58,200
-80,900
| -58% | -$2.66M |
|
|
STEL
2132
DELISTED
Stellar Bancorp
STEL
| $1.9M | ﹤0.01% |
72,010
-4,100
| -5% | -$109K |
|
|
FMTX
2133
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $1.9M | ﹤0.01% |
+81,900
| New | +$1.94M |
|
2134
Green Dot
GDOT
$771M
| $1.9M | ﹤0.01% |
+37,700
| New | +$1.81M |
|
2135
Norwood Financial Corp
NWFL
$376M
| $1.9M | ﹤0.01% |
74,325
-23,300
| -24% | -$592K |
|
2136
Live Ventures
LIVE
$31.9M
| $1.89M | ﹤0.01% |
51,099
+1,700
| +3% | +$74.9K |
|
2137
Amerant Bancorp
AMTB
$1.14B
| $1.89M | ﹤0.01% |
76,300
+7,100
| +10% | +$168K |
|
|
MAG
2138
DELISTED
MAG Silver
MAG
| $1.89M | ﹤0.01% |
+116,500
| New | +$2.18M |
|
|
PPIH
2139
Perma-Pipe International
PPIH
$218M
| $1.89M | ﹤0.01% |
243,193
-4,500
| -2% | -$32K |
|
2140
Invesco BuyBack Achievers ETF
PKW
$1.8B
| $1.88M | ﹤0.01% |
20,900
+18,500
| +771% | +$1.7M |
|
2141
Innospec
IOSP
$2.31B
| $1.88M | ﹤0.01% |
22,300
-18,700
| -46% | -$1.67M |
|
|
CBAY
2142
DELISTED
Cymabay Therapeutics
CBAY
| $1.87M | ﹤0.01% |
512,591
-283,629
| -36% | -$1.12M |
|
|
TSC
2143
DELISTED
TriState Capital Holdings, Inc.
TSC
| $1.86M | ﹤0.01% |
88,200
+1,600
| +2% | +$32.4K |
|
2144
AnaptysBio
ANAB
$1.73B
| $1.86M | ﹤0.01% |
68,700
-155,600
| -69% | -$3.95M |
|
|
GATO
2145
DELISTED
Gatos Silver, Inc.
GATO
| $1.86M | ﹤0.01% |
+160,105
| New | +$2.23M |
|
2146
iShares MSCI France ETF
EWQ
$332M
| $1.86M | ﹤0.01% |
50,000
+21,900
| +78% | +$838K |
|
2147
Tecnoglass Holdings Inc.
TGLS
$1.86B
| $1.86M | ﹤0.01% |
85,400
+26,400
| +45% | +$556K |
|
2148
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.43B
| $1.85M | ﹤0.01% |
+49,100
| New | +$1.87M |
|
2149
Granite Construction
GVA
$5.56B
| $1.85M | ﹤0.01% |
+46,765
| New | +$1.85M |
|
2150
NovaGold Resources
NG
$3.48B
| $1.85M | ﹤0.01% |
268,441
+56,038
| +26% | +$415K |
|
Similar funds
Jim Simons's Q3 2021 Portfolio in Review
As of Q3 2021, Jim Simons held 4,070 positions worth $77.4B, down 3.3% from $80.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons's Q3 2021 filing shows 663 new, 931 increased, 1,797 reduced and 653 closed positions. Its largest new stake was Adobe: 1,030,433 shares worth $593M. The largest sale was Amazon, an estimated $897M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Technology and Consumer Staples.
- Jim Simons's largest Q3 2021 buy was Adobe: 1,030,433 shares worth $593M.
- Jim Simons added most to Nike in Q3 2021, an estimated $453M increase.
- Jim Simons's biggest Q3 2021 reduction was Moderna, cutting an estimated $438M.
- Jim Simons fully exited Amazon in Q3 2021, selling an estimated $897M.
- Jim Simons's ten largest holdings make up 12% of its $77.4B portfolio in Q3 2021.
- Jim Simons opened 663 new positions and closed 653 in Q3 2021.
- Jim Simons's portfolio value fell 3.3% quarter-over-quarter to $77.4B.
Based on Renaissance Technologies's 13F filing for Q3 2021, filed 12 Nov 2021.